Since 2008, the BPI Theater, a live, interactive amphitheater located at the heart of the BioProcess Zone (booth #375), provides biopharmaceutical professionals with a dedicated destination to meet, network, listen and learn about the latest scientific, technology, business, and financial trends impacting biopharmaceutical research, development, and manufacturing.
In 2018, this live, three-day, complimentary event consists of targeted panel discussions and individual presentations focusing on Emerging Therapies, Techniques, and Technologies.
Wednesday, June 6
EMERGING TECHNIQUES & TECHNOLOGIES: Drug Product Supply Challenges, Speed to Market, Capacity vs. Cost, SUS vs, Stainless, Analytics & Formulation, Single-Use Bioprocessing
BioProcess Insider Daily - One-on-One Live Executive Interviews
10:15 – 10:30am Patrick Lucy, CBO, Pfenex
10:30 – 10:45am Angus Turner, VP, WuXi Biologics
Rapid, Reliable Response to Biologic Drug Substance and Drug Product Supply Challenges
11:00 am - 11:20 am
Speaker: Scott Battist, VP, GM & Site Head – Drug Substance Plant & BJ Hull, VP, GM & Site Head – Drug Product Plant, Emergent Bio
Speed Matters – Gene to GMP in 9 Months
11:20 am – 11:40 am
Speaker: Igor Fisch, PhD., CEO, Selexis, SA
It’s All About Speed: Getting to Early-Development Clinical Trials Quickly
11:40 am – 12:00 pm
Speaker: David J. Kenyon, Sr. Director, Global Scientific and Technical Affairs, Patheon, part of Thermo Fisher Scientific
Using New Technologies to Compress Timelines, Increase Capacity, and Reduce Costs – Why, When and How
12:00 pm - 1:00 pm
Moderator: Tom Ransohoff, Vice President & Principle Consultant, BioProcess Technology Consultants, Inc.
-Rajesh Beri, Technical Director BioManufacturing, Research & Technology, Lonza Pharma & Biotech
-Geoffrey Hodge, Chief Technical Officer, UNUM Therapeutics
-Chris Love, Professor, MIT
-Jorg Thommes, Senior Vice President, Pharmaceutical Sciences & Technology, Visterra, Inc.
Industry experts discuss and explore the need for new technologies in our industry as well as the roles of academia, suppliers, end-users and consortia in the current adoption cycle.
Lessons learned in what works (and what doesn’t) will be shared along with potential strategies to improve new technology adoption practices in the future.
Capacity Strategies – The strategy Behind the Large Scale SUS vs. Stainless Steel Investment
1:00 pm - 2:00 pm
Moderator: Dan Stanton, Editor, BioProcess Insider
-Weichang Zhou, SVP, CTO,WuXi Biologics
-Jenifer Wheat, Head of Commercial Development for Mammalian Manufacturing, Lonza Pharma & Biotech
-Roger Lias, President & CEO, Avid Bioservices
-Jim Vogel, Founder and Director, The BioProcess Institute
Often heralded as a fundamental part of the ‘facility of the future,’ single-use is now a prevalent part of the bioprocessing space. But does this mean industry’s historic reliance on stainless steel and fixed facilities is over?
In this roundtable discussion, we discuss the wealth of investment in single-use equipment and flexible manufacturing solutions by CDMOs over the past few years and pit this against what looks like a resurgence in fixed-cost stainless steel plants from a certain group of biomanufacturers. How do these differing uses of resources feed Biopharma and Biotech’s clinical and commercial demands, and what financial and regulatory risks are CDMOs facing through their capacity choices?
Emerging Technologies & Strategies to Accelerate Process Development and Time to Market
2:00 pm – 2:20 pm
Speaker: Gustavo Mahler, President & CEO, AGC Biologics
Future Proofing and Understanding Your Molecule with Contemporary Analytics and Formulation Approaches
2:20 pm – 2:40 pm
Speaker: Greg Adams, Senior Director, Global Analytical Strategy & Development, FUJIFILM Diosynth Biotechnologies
Thinking Outside the Bag: Utilizing Single-Use Technology to Drive Innovation at the Benchtop Scale
2:40 pm – 3:00 pm
Speaker: Cristy Botens, Product Manager, Bioprocessing, Distek
Bringing Biologic Products to Market Faster by Partnering with a Single Services Provider from Development Through Commercial Supply
3:00 pm – 3:20 pm
Speaker: Andrew Sandford, VP, Business Development, Catalent Biologics
Product Development through Commercial Production – Guiding Your Biologic from Start to Finish
3:20 pm – 3:40 pm
Speaker: Eunyoung Yang, Team Leader, CDO Business Development Team, Samsung Biologics
The Perks and Pitfalls of a Single-Use Biopharmaceutical Facility
3:40 pm – 4:00 pm
Speaker: Sun Ra Bullins, Director of Manufacturing, Avid Bioservices
CMO Fusion: Where Stainless Steel meets Disposable Technology
4:00 pm – 4:20 pm
Speaker: Molly McGlaughlin, Director, Strategy and Business Development and Jim Stout, Director, Process Science, BioVectra
For the full BioProcess Theater Schedule, please visit convention.bio.org/bioprocess-theater
Session ID: 58182